BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20595784)

  • 1. Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice.
    Tsukumo Y; Harada D; Manabe H
    J Pharmacol Sci; 2010; 113(3):255-62. PubMed ID: 20595784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice).
    Nakasone T; Sato T; Matsushima Y; Inoue T; Kamei C
    Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):202-6. PubMed ID: 25578901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice.
    Tsukumo Y; Matsumoto Y; Miura H; Yano H; Manabe H
    J Pharmacol Sci; 2011; 115(1):27-35. PubMed ID: 21157120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice.
    Kim HJ; Kim DK; Kim H; Koh JY; Kim KM; Noh MS; Lee S; Kim S; Park SH; Kim JJ; Kim SY; Lee CH
    Br J Pharmacol; 2008 Jul; 154(5):1073-8. PubMed ID: 18536755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
    Kamei J; Nagase H
    Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T; Amano T; Ohmori K; Manabe H
    Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin.
    Andoh T; Saito A; Kuraishi Y
    J Invest Dermatol; 2009 Dec; 129(12):2854-60. PubMed ID: 19657356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions.
    Andoh T; Haza S; Saito A; Kuraishi Y
    Exp Dermatol; 2011 Nov; 20(11):894-8. PubMed ID: 21824199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of 5-lipoxygenase metabolite in itch-associated response of mosquito allergy in mice.
    Kuraishi Y; Ohtsuka E; Nakano T; Kawai S; Andoh T; Nojima H; Kamimura K
    J Pharmacol Sci; 2007 Sep; 105(1):41-7. PubMed ID: 17827870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
    Andoh T; Katsube N; Maruyama M; Kuraishi Y
    J Invest Dermatol; 2001 Dec; 117(6):1621-6. PubMed ID: 11886531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Leukotriene B4 Released from Keratinocytes in Itch-associated Response to Intradermal Interleukin-31 in Mice.
    Andoh T; Harada A; Kuraishi Y
    Acta Derm Venereol; 2017 Aug; 97(8):922-927. PubMed ID: 28512667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H(4) receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model.
    Suwa E; Yamaura K; Oda M; Namiki T; Ueno K
    Eur J Pharmacol; 2011 Sep; 667(1-3):383-8. PubMed ID: 21664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
    Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
    Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence of involvement of nitric oxide pathway in anti-pruritic effects of sumatriptan in chloroquine-induced scratching in mice.
    Haddadi NS; Ostadhadi S; Shakiba S; Afshari K; Rahimi N; Foroutan A; Dehpour AR
    Fundam Clin Pharmacol; 2018 Feb; 32(1):69-76. PubMed ID: 28815720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
    Inagaki N; Shiraishi N; Igeta K; Nagao M; Kim JF; Chikumoto T; Itoh T; Katoh H; Tanaka H; Nagai H
    Eur J Pharmacol; 2010 Jan; 626(2-3):283-9. PubMed ID: 19818345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.
    Sugimoto Y; Umakoshi K; Nojiri N; Kamei C
    Eur J Pharmacol; 1998 Jun; 351(1):1-5. PubMed ID: 9698198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist.
    Akasaka Y; Yoshida T; Tsukahara M; Hatta A; Inoue H
    Eur J Pharmacol; 2011 Nov; 670(1):175-9. PubMed ID: 21925497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
    Yamashita H; Makino T; Mizukami H; Nose M
    Eur J Pharmacol; 2007 Jun; 563(1-3):233-9. PubMed ID: 17336291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis.
    Fujii M; Takeuchi K; Umehara Y; Takeuchi M; Nakayama T; Ohgami S; Asano E; Nabe T; Ohya S
    Eur J Pharmacol; 2018 Oct; 836():57-66. PubMed ID: 30125561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis.
    Maekawa T; Yamaguchi-Miyamoto T; Nojima H; Kuraishi Y
    Jpn J Pharmacol; 2002 Oct; 90(2):193-6. PubMed ID: 12419891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.